Literature DB >> 17934022

Is continuing medical education a drug-promotion tool?: YES.

Michael A Steinman1, Robert B Baron.   

Abstract

Mesh：

Year:  2007        PMID： 17934022      PMCID： PMC2231419     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

1.  Separating continuing medical education from pharmaceutical marketing.

Authors:  A S Relman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

2.  Is academic medicine for sale?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Physicians and the pharmaceutical industry (update 2001).

Authors: 
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

4.  Changes in drug prescribing patterns related to commercial company funding of continuing medical education.

Authors:  M A Bowman; D L Pearle
Journal:  J Contin Educ Health Prof       Date:  1988       Impact factor: 1.355

5.  The future sponsorship of CME in Canada: industry, government, physicians or a blend?

Authors:  Bernard Marlow
Journal:  CMAJ       Date:  2004-07-20       Impact factor: 8.262

6.  What's wrong with CME?

Authors: 
Journal:  CMAJ       Date:  2004-03-16       Impact factor: 8.262

7.  Commercial support and continuing medical education.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

8.  For sale: physicians' prescribing data.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

9.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Authors:  Troyen A Brennan; David J Rothman; Linda Blank; David Blumenthal; Susan C Chimonas; Jordan J Cohen; Janlori Goldman; Jerome P Kassirer; Harry Kimball; James Naughton; Neil Smelser
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

Review 10.  Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

Authors:  Michael A Steinman; Lisa A Bero; Mary-Margaret Chren; C Seth Landefeld
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391
View more
  5 in total

1.  Medical science and society.

Authors:  Carlton Gyles
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

2.  Bias-free health care.

Authors:  Joel Weinstein
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

3.  Industry involvement in continuing medical education: time to say no.

Authors:  Sheryl Spithoff
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

4.  Commercial influence and learner-perceived bias in continuing medical education.

Authors:  Michael A Steinman; Christy K Boscardin; Leslie Aguayo; Robert B Baron
Journal:  Acad Med       Date:  2010-01       Impact factor: 6.893

5.  Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies' websites.

Authors:  Alice Fabbri; Giorgia Gregoraci; Dario Tedesco; Filippo Ferretti; Francesco Gilardi; Diego Iemmi; Cosima Lisi; Angelo Lorusso; Francesca Natali; Edit Shahi; Alessandro Rinaldi
Journal:  BMJ Open       Date:  2016-06-01       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.